It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Pfizer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
White House backs Pfizer’s move to begin vaccine exports

World May 4, 2021

White House backs Pfizer’s move to begin vaccine exports

by Josh Wingrove

Early U.S. production wasn’t subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.

Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds

World / Science & Health May 1, 2021

Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds

A single dose of the vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19.

Japan to approve Moderna vaccine as soon as May 21, report says

National May 1, 2021

Japan to approve Moderna vaccine as soon as May 21, report says

The Moderna vaccine would be the second to get approved in Japan and will be used in the nation’s large inoculation centers that will open in Tokyo and Osaka from May 24, the report said.

Japanese frustrated over vaccine rollout after learning of EU exports

National May 1, 2021

Japanese frustrated over vaccine rollout after learning of EU exports

by Lisa Du

The EU has said that it had authorized some 52.3 million doses made in European factories for export to Japan, the highest volume among all 43 countries to which vaccines have been shipped.

Tokyo to get SDF-staffed, large-scale vaccination site amid slow rollout

National Apr 27, 2021

Tokyo to get SDF-staffed, large-scale vaccination site amid slow rollout

by Tomohiro Osaki

Medically licensed SDF personnel are expected to administer Moderna and AstraZeneca vaccines to about 900,000 people age 65 or older living in the capital and neighboring prefectures.

Deal for more Pfizer shots may allow Japan to cut reliance on AstraZeneca vaccine

National Apr 21, 2021

Deal for more Pfizer shots may allow Japan to cut reliance on AstraZeneca vaccine

Pfizer is expected to provide an additional 50 million doses by September in a contract that could be agreed on this month, a report said Wednesday.

Japan to secure enough vaccines for all residents by end of September

National Apr 18, 2021

Japan to secure enough vaccines for all residents by end of September

Pfizer has accepted Prime Minister Yoshihide Suga's request to supply additional doses of the shots, vaccine chief Taro Kono said Sunday.

Suga to hold phone talks with Pfizer executive

National Apr 16, 2021

Suga to hold phone talks with Pfizer executive

Some Japanese government sources said Suga is arranging to hold talks with Pfizer CEO Albert Bourla via telephone on Friday or Saturday Japan time.

South African variant can 'break through' Pfizer vaccine, Israeli study says

World Apr 11, 2021

South African variant can 'break through' Pfizer vaccine, Israeli study says

The study suggests the vaccine is less effective against the South African variant, compared with the original coronavirus and a variant first identified in Britain.

Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds

World Mar 30, 2021

Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds

The results validate earlier studies that had indicated the vaccines begin to work soon after a first dose, and confirm that they also prevent asymptomatic infections.

Japan reports 47 anaphylaxis cases after 580,000 vaccine shots, but ministry confirms safety

National / Science & Health Mar 27, 2021

Japan reports 47 anaphylaxis cases after 580,000 vaccine shots, but ministry confirms safety

All recovered after receiving treatment, according to the ministry, with its panel of experts concluding that there are no serious concerns about the safety of the vaccine at this time.

The ex-Pfizer scientist who became an anti-vaccination hero

World / Science & Health Mar 20, 2021

The ex-Pfizer scientist who became an anti-vaccination hero

by Steve Stecklow and Andrew Macaskill

In recent months, Michael Yeadon has emerged as an unlikely hero of the so-called anti-vaxxers, whose adherents question the safety of many vaccines, including for the coronavirus.

« 1 … 7 8 9 … 13 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times